Single and Multiple Ascending Doses of NTX-253 in Healthy Participants and Participants With Stable Schizophrenia
Clinical trial NCT07344948 · RECRUITING
Trial details
- NCT number
- NCT07344948
- Sponsor
- Neurosterix
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-03
- Primary completion
- 2026-05-01
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.